NEW YORK, Aug. 28 (GenomeWeb News) - Transgenomic said today that it has signed securities purchase deals worth a total of $4.5 million with a number of select investors.

The Omaha, Neb.-based company said that the biggest purchasers were two of its largest institutional investors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.